Found: 12
Select item for more details and to access through your institution.
Integrins in the Spotlight of Cancer.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 12, p. 2037, doi. 10.3390/ijms17122037
- By:
- Publication type:
- Article
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1772, doi. 10.3390/jcm9061772
- By:
- Publication type:
- Article
Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 3, p. 648, doi. 10.3390/jcm9030648
- By:
- Publication type:
- Article
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928635
- By:
- Publication type:
- Article
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920928635
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2586, doi. 10.3390/cancers16142586
- By:
- Publication type:
- Article
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919853196
- By:
- Publication type:
- Article
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919853196
- By:
- Publication type:
- Article
Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 6249, doi. 10.2147/CMAR.S308029
- By:
- Publication type:
- Article
Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI.
- Published in:
- Oncology, 2018, v. 94, n. 5, p. 306, doi. 10.1159/000486678
- By:
- Publication type:
- Article
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article